NexThera Completes First Patient Enrollment in US Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD

NexThera Co., Ltd. announced that it has completed the first patient enrollment for its Phase I/IIa clinical trial of NT-101, a novel eye drop treatment for wet AMD, at a clinical trial site in Pennsylvania.